Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
5.09
+0.04 (0.79%)
At close: Jan 8, 2026, 4:00 PM EST
5.11
+0.02 (0.39%)
After-hours: Jan 8, 2026, 5:54 PM EST
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $268.22 million as of January 8, 2026. Its market cap has increased by 339.22% in one year.
Market Cap
268.22M
Enterprise Value
251.27M
1-Year Change
339.22%
Ranking
Category
Stock Price
$5.09
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $268.22M, an increase of 307.98%. That is a compound annual growth rate of 41.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 266.11M | -3.44% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.48B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |